| 1. |
A record price of $US20 000 has been revealed by manufacturing partners Roche and Trimeris for a one-year supply of their new drug enfuvirtide ['Fuzeon'] |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 2. |
COX-3: potential drug target of the future |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 3. |
Diuretics are not more effective than newer antihypertensive therapies, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 4. |
Treatment plan aims to reduce secondary events in stroke |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 5-5
&NA;,
Preview
|
|
摘要:
The risk factors for stroke are well established, as are the steps needed to preventsecondary strokes. However, there remains a substantial divide between what is known in theory, and the extent to which those risks are reduced in the real world. The reasons for this divide include a lack of awareness of the signs of stroke, a lack of knowledge about modifiable risk factors on the part of patients, a lack of prevention programmes in hospitals and in the community, and poor utilisation of existing programmes. Now, a team of stroke specialists at the University of California at Los Angeles (UCLA) Medical Center, US, has developed a formalised, post-discharge treatment programme which they say will provide integrated, methodical and effective follow-up throughout the first year after a patient's stroke. Maintaining such a structured programme, the researchers believe, would help reduce the risk of subsequent events by closing some of the practice-gap between what physicians know and what information gets passed on to the patient.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 5. |
Basiliximab: economic advantage for renal transplantation in Japan |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 6. |
Alitretinoin has proven beneficial in patients with chronic hand dermatitis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 7. |
Emtricitabine effective in paediatric HIV infections |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 9-10
C Bankhead,
Preview
|
|
摘要:
Although highly active antiretroviral therapy (HAART) has proven effective in the treatment of HIV infections, safety and toxicity remain key considerations, particularly in children. Emtricitabine [FTC, 'Coviracil'] is a new nucleoside reverse transcriptase inhibitor (NRTI) that has demonstrated potent activity against HIV in adults treated with once-daily HAART regimens. However, the safety and efficacy of emtricitabine have not been fully evaluated in children. Two studies presented at the 10th Conference on Retroviruses and Opportunistic Infections [Boston, US; February 2003] have provided evidence that treatment of children with emtricitabine achieves a level of systemic exposure comparable to that observed in adults, and that the drug is also virologically active and well tolerated in children.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 8. |
BMP-9: a new player in glucose homeostasis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 9. |
Short-term treatment with ephedrine- and ephedra-containing supplements induces moderate weight loss, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 10. |
Levetiracetam provides effective relief in a range of pain syndromes, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1380,
2003,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
